Thyroid Cancer Treatment in Raipur

The thyroid is a butterfly-shaped gland just below the Adam's apple that produces hormones that regulate metabolism, heart rate, and energy levels throughout the body. Most people give no thought to it until something goes wrong. A neck lump, a voice that has gradually deepened, or a swallowing discomfort misattributed to reflux are often how thyroid cancer announces itself.

Thyroid cancer develops when thyroid cells undergo malignant transformation. For most histological types, it is one of the most treatable cancers, with a high cure rate for well-differentiated thyroid cancer before distant spread. This favourable prognosis depends on accurate diagnosis, appropriate surgery, post-operative radioactive iodine where indicated, and long-term surveillance.

Types of Thyroid Cancer

Different types of thyroid cancers are:

• Papillary thyroid carcinoma: The most common thyroid cancer, accounting for 80% of cases. It grows slowly and tends to spread to the cervical lymph nodes, but even with nodal involvement, the long-term prognosis with appropriate treatment is excellent. Treated with surgery and post-operative radioiodine for higher-risk cases
• Follicular thyroid carcinoma: Spreads via the bloodstream to the lungs and bones rather than to lymph nodes. Vascular invasion distinguishes it from benign follicular adenoma so FNAC cannot reliably make this distinction; full surgical excision and histological examination of the specimen is required
• Hurthle cell carcinoma: A follicular carcinoma variant considered more aggressive with lower radioactive iodine uptake, making RAI treatment less effective
• Medullary thyroid carcinoma (MTC): Arises from C-cells that produce calcitonin and is an extremely sensitive tumour marker. Around 25% of cases are hereditary (MEN2A/2B), making genetic counselling and family cascade testing important. MTC does not respond to radioactive iodine; surgery is the only curative treatment
• Anaplastic thyroid carcinoma: The rarest and most aggressive type, it grows rapidly, often locally advanced or metastatic at diagnosis. Managed with multimodal treatment: surgery where possible, radiation therapy, and targeted therapy (dabrafenib plus trametinib for BRAF V600E-mutated tumours).

Signs and Symptoms of Thyroid Cancer

Thyroid cancer is most often asymptomatic early, and many cases are found incidentally on imaging. When symptoms occur, they reflect tumour growth or spread to adjacent structures:

• A lump or swelling in the front of the neck
• Hoarseness or voice change from compression or invasion of the recurrent laryngeal nerve
• Difficulty swallowing, particularly with solid foods as the tumour impinges on the oesophagus
• A sense of pressure or tightness in the neck or difficulty breathing from tracheal compression
• Enlarged painless lymph nodes in the neck alongside the thyroid mass
• Unexplained weight loss or fatigue in advanced disease.

Causes of Thyroid Cancer

The most well-established environmental risk factor is exposure to ionizing radiation, especially during childhood. While therapeutic radiation to the head and neck or direct radioactive exposure notably increases the likelihood of developing thyroid cancer, standard medical diagnostic radiation does not carry the same risk.

Genetics also play a significant role, particularly in medullary thyroid carcinoma (MTC), which has a strong hereditary link associated with RET gene mutations. Additionally, familial papillary carcinoma can occur, and having a positive family history generally elevates an individual's overall risk.

Risk Factors of Thyroid Cancer

Certain factors increase the risk of thyroid cancer. They are:

• Female sex - thyroid cancer is approximately three times more common in women than men
• Prior head, neck or chest radiation particularly in childhood
• Increasing age (risk varies by thyroid cancer type)
• Personal history of thyroid nodules or goitre
• Iodine deficiency or excess in some populations
• Obesity
• Previous thyroid disease including chronic thyroid inflammation.

Complications of Thyroid Cancer

If left untreated or diagnosed at an advanced stage, thyroid cancer can spread beyond the thyroid gland and lead to several complications. They are:

• Regional lymph node metastases: Papillary carcinoma frequently spreads to cervical nodes 
• Distant metastases: Follicular and anaplastic carcinoma can metastasise to the lung, bone, and brain. Bony metastases can cause fractures. 
• Recurrent laryngeal nerve injury: Results from tumour invasion or as a surgical complication and causes hoarseness if unilateral and breathing difficulty if bilateral. 
• Hypoparathyroidism: Inadvertent parathyroid gland removal causes hypocalcaemia resulting in tingling, cramps and in severe cases seizures. Temporary hypoparathyroidism is common after total thyroidectomy whereas permanent hypoparathyroidism is the most significant long-term surgical complication
• Local invasion: Anaplastic carcinoma may invade the trachea, oesophagus, and great vessels causing airway compromise and haemorrhage
• Hypothyroidism after thyroidectomy: Total thyroidectomy requires lifelong levothyroxine replacement. Suppressive doses (lower TSH) reduce TSH-driven tumour stimulation for differentiated thyroid cancer.

Diagnosis of Thyroid Cancer

Diagnosing thyroid cancer involves a combination of clinical evaluation, imaging and laboratory tests:

• Thyroid ultrasound: This is a first-line investigation and characterises nodule features (TIRADS scoring) to guide biopsy decisions. Performed under endocrinology guidance
• Fine needle aspiration cytology (FNAC): Ultrasound-guided needle sampling categorising nodules as benign, malignant, suspicious, follicular neoplasm or non-diagnostic
• Thyroid function tests: Measure TSH, free T4, free T3. Most thyroid cancers do not cause dysfunction. A suppressed TSH with a nodule suggests an autonomous functioning nodule which has lower cancer risk
• Serum calcitonin: Essential when MTC is suspected or for family members of MTC patients. Elevated calcitonin is highly specific for MTC and correlates with disease extent
• CT and MRI: For advanced disease CT and MRI assess tracheal or oesophageal involvement, retrosternal extension and cervical nodal extent before surgery
• PET CT - uMI 550: Used in radioiodine negative differentiated thyroid cancer where dedifferentiated cells no longer concentrate iodine. The uMI 550's 2.76mm resolution and Time-of-Flight imaging identify distant metastases and recurrent disease. Also used for MTC and anaplastic thyroid carcinoma staging
• Molecular testing: RET mutation testing for MTC and family members. 

Treatment of Thyroid Cancer

• Surgery - thyroidectomy: Primary treatment for most thyroid cancers. Hemithyroidectomy for low-risk papillary microcarcinoma or indeterminate cytology. Total thyroidectomy for most differentiated cancers above 1cm, follicular carcinoma, medullary carcinoma, and multifocal disease. Recurrent laryngeal nerve identification and parathyroid preservation are the central technical challenges
• Neck dissection: Central compartment dissection for MTC and papillary carcinoma with confirmed central nodal involvement; lateral dissection for confirmed lateral nodal disease. 
• Radioactive iodine (RAI) ablation: After total thyroidectomy for differentiated thyroid cancer RAI ablation destroys residual thyroid tissue and microscopic metastatic disease. High-dose RAI for distant metastases; pulmonary micrometastases frequently achieve complete remission. MTC and anaplastic carcinoma do not respond to RAI
• TSH suppression therapy: Levothyroxine at doses suppressing TSH below normal reducing TSH-driven stimulation of residual cancer cells. 
• External beam radiation: For locally advanced or incompletely resected thyroid cancer and symptomatic bone metastases delivered on the Elekta Versa HD with IMRT precision protecting the spinal cord, oesophagus and trachea
• Targeted therapy: Targeted medicines for radioiodine-refractory differentiated thyroid carcinoma, BRAF V600E-mutated anaplastic carcinoma and progressive medullary carcinoma
• Immunotherapy: Checkpoint inhibitors in selected advanced, treatment-refractory thyroid cancers particularly anaplastic carcinoma in multimodal treatment.

When Should You See a Doctor

Contact a doctor if you experience:

• A new lump or swelling in the front of the neck 
• New or progressive difficulty swallowing
• A rapidly enlarging neck mass as rapid growth raises concern for anaplastic carcinoma 
• Family history of medullary thyroid carcinoma or MEN2 syndrome.

Why Choose Ramkrishna CARE Hospitals for Thyroid Cancer Treatment in Raipur?

Successful thyroid cancer treatment requires accurate diagnosis, specialised surgical expertise and coordinated long-term care. Ramkrishna CARE Hospitals provides comprehensive, personalised treatment under one roof:

• Endocrinology-led evaluation: Endocrinology-qualified specialist leading thyroid nodule assessment & cancer management with full hormone laboratory capability (TSH, calcitonin, thyroglobulin and antibodies) and ultrasound guided FNAC within the department
• Multidisciplinary tumour board: Our endocrinologists, head and neck surgical oncologists, nuclear medicine specialists, radiation oncologists and radiologists review every case before treatment accounting for age, comorbidities and quality-of-life priorities
• Subspecialty thyroid surgery: Total thyroidectomy, hemithyroidectomy and neck dissection performed by surgeons with specific head and neck endocrine training including meticulous nerve identification and parathyroid preservation; intraoperative nerve monitoring for high-risk cases
• PET CT staging: The uMI 550's 2.76mm resolution and Time-of-Flight imaging stage advanced thyroid cancer, identify radioiodine-negative recurrent disease and monitor targeted therapy response. Primary staging modality for MTC and anaplastic carcinoma where radioiodine is not applicable
• Elekta Versa HD radiation: Adjuvant and definitive radiation delivered with IMRT precision protecting the spinal cord, trachea and oesophagus. HexaPOD positioning and IGRT verified delivery at each fraction
• Radioactive iodine coordination: Postoperative RAI coordinated with nuclear medicine; patient preparation including hypothyroid withdrawal or recombinant TSH stimulation managed by the endocrinology team
• Structured long-term surveillance: Thyroglobulin and antibody monitoring, neck ultrasound and PET CT (where indicated) are organised within a programme coordinated by endocrinology after treatment for differentiated thyroid cancer.

Conclusion

For most patients thyroid cancer is a highly treatable malignancy. Achieving the best outcome requires accurate histological classification, appropriate surgical planning, postoperative radioiodine where indicated and long term surveillance that detects recurrence while it is still manageable.

At Ramkrishna CARE Hospitals, Raipur, the complete thyroid cancer programme including endocrinology-led evaluation, subspecialty thyroid surgery, PET CT staging on the uMI 550, precision radiation on the Elekta Versa HD, radioiodine coordination and long-term surveillance is available within a single multidisciplinary programme for patients across Chhattisgarh.